By InvestAdvocate

Lagos (INVESTADVOCATE)-Drug manufacturer, GlaxoSmithKline Consumer Nigeria Plc Tuesday announced a 3.4 percent (3.4%) increase in its profit after tax (PAT) for 2013 audited year end.

To post the 3.4% in PAT, the drug maker in year 2012 declared N2.823 billion compared to N2.919 billion reported in the review period of 2013.

Profit before tax (PBT) also grew by the same margin (3.4%) as GSK Nigeria declared N4.314 billion compared to N4.171 billion recorded in the 2012 audited year end.

While the drug manufacturer posted a revenue of N29.183 billion compared to N25.305 billion in the same period of 2012; indicating a growth in revenue of 15.3%.